A one year longitudinal study of cytokine genes and depression in breast cancer

Journal of Affective Disorders

Volumn 148, Issue 1, 2013, Pages 57-65

  Kim, Jae Min ^a   Stewart, Robert ^b   Kim, Seon Young ^a   Kang, Hee Ju ^a   Jang, Ji Eun ^a   Kim, Sung Wan ^a   Shin, Il Seon ^a   Park, Min Ho ^c   Yoon, Jung Han ^c   Park, Sung Woo ^d   Kim, Young Hoon ^d   Yoon, Jin Sang ^a  

^a Chonnam National University Medical School   (South Korea)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c Chonnam National University Hwasun Hospital and Medical School   (South Korea)

^d Inje University College of Medicine   (South Korea)

Author keywords

Breast cancer; Cytokines; Depression; Genetic association study; Interleukins

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEPRESSION; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENE FREQUENCY; GENOTYPE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; PARTIAL MASTECTOMY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CYTOKINES; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-4; INTERLEUKIN-6; INTERLEUKIN-8; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84876962428     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2012.11.048     Document Type: Article

References (63)

1. American Joint Committee on Cancer (AJCC) AJCC Cancer Staging Handbook from the AJCC Cancer Staging Manual sixth ed. 2002 Springer-Verlag New York pp. 257-281
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders fourth ed. 1994 American Psychiatric Press Washington, DC
3. H. Anisman, A.V. Ravindran, J. Griffiths, and Z. Merali Interleukin-1 beta production in dysthymia before and after pharmacotherapy Biological Psychiatry 46 1999 1649 1655
4. T.A. Babcock, and J.M. Carlin Transcriptional activation of indoleamine dioxygenase by interleukin 1 and tumor necrosis factor alpha in interferon-treated epithelial cells Cytokine 12 2000 588 594
5. I.H. Benoy, R. Salgado, P. Van Dam, K. Geboers, E. Van Marck, S. Scharpé, P.B. Vermeulen, and L.Y. Dirix Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival Clinical Cancer Research 10 2004 7157 7162
6. B.B. Blomberg, J.P. Alvarez, A. Diaz, M.G. Romero, S.C. Lechner, C.S. Carver, H. Holley, and M.H. Antoni Psychosocial adaptation and cellular immunity in breast cancer patients in the weeks after surgery: an exploratory study Journal of Psychosomatic Research 67 2009 369 376
7. J. Bower Behavioral symptoms in patients with breast cancer and survivors Journal of Clinical Oncology 26 2008 768 777
8. P. Borkowska, K. Kucia, S. Rzezniczek, M. Paul-Samojedny, M. Kowalczyk, A. Owczarek, R. Suchanek, T. Medrala, and J. Kowalski Interleukin-1beta promoter (-31T/C and -511C/T) polymorphisms in major recurrent depression Journal of Molecular Neuroscience 44 2011 12 16
9. S. Campbell, M. Marriott, C. Nahmias, and G.M. MacQueen Lower hippocampal volume in patients suffering from depression: a meta-analysis American Journal of Psychiatry 161 2004 598 607
10. A. Caspi, A.R. Hariri, A. Holmes, R. Uher, and T.E. Moffitt Serotonin transporter gene and its implications for studying complex diseases and traits American Journal of Psychiatry 167 2010 509 527
11. M.J. Cho, J. Kim, H.J. Jeon, T. Suh, I. Chung, J.P. Hong, J. Bae, D. Lee, J. Park, S. Cho, C.J. Lee, and B. Hahm Lifetime and 12-month prevalence of DSM-IV psychiatric disorders among Korean adults The Journal of Nervous and Mental Disease 195 2007 203 210
12. A.J. de Craen, D. Posthuma, E.J. Remarque, A.H. van den Biggelaar, R.G. Westendorp, and D.I. Boomsma Heritability estimates of innate immunity: an extended twin study Genes and Immunity 6 2005 167 170
13. J. Ferlay, H.R. Shin, F. Bray, and D. Forman Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 International Journal of Cancer 127 2010 2893 2917
14. A. Friebe, M. Horn, F. Schmidt, G. Janssen, M.H. Schmid-Wendtner, M. Volkenandt, A. Hauschild, C.H. Goldsmith, and M. Schaefer Dose-dependent development of depressive symptoms during adjuvant interferon-alpha treatment of patients with malignant melanoma Psychosomatics 51 2010 466 473
15. J. Giese-Davis, K. Collie, K.M. Rancourt, E. Neri, H.C. Kraemer, and D. Spiegel Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: a secondary analysis Journal of Clinical Oncology 29 2011 413 420
16. W.M. Howell, Rose, and M.J. Zerilli Cytokine gene polymorphisms, cancer susceptibility, and prognosis Journal of Nutrition 137 2007 194S 199S
17. J.P. Hwang, S.J. Tsai, C.J. Hong, C.H. Yang, C.D. Hsu, and Y.J. Liou Interleukin-1 beta -511C/T genetic polymorphism is associated with age of onset of geriatric depression NeuroMolecular Medicine 11 2009 322 327
18. C.M. Jacobson, B. Rosenfeld, H. Pessin, and W. Breitbart Depression and IL-6 blood plasma concentrations in advanced cancer patients Psychosomatics 49 2008 64 66
19. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics CA A Cancer Journal for Clinicians 60 2010 277 300
20. T.Y. Jun, C.U. Pae, H. Hoon, J.H. Chae, W.M. Bahk, K.S. Kim, and A. Serretti Possible association between -G308A tumour necrosis factor-α gene polymorphism and major depressive disorder in the Korean population Psychiatric Genetics 13 2003 179 181
21. K.S. Kendler, J.W. Kuhn, J. Vittum, C.A. Prescott, and B. Riley The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression Archives of General Psychiatry 62 2005 529 535
22. J.M. Kim, S.W. Kim, R. Stewart, S.Y. Kim, I.S. Shin, M.H. Park, J.H. Yoon, J.S. Lee, S.W. Park, Y.H. Kim, and J.S. Yoon Serotonergic and BDNF genes associated with depression one week and one year after mastectomy for breast cancer Psychosomatic Medicine 74 2012 8 15
23. J.M. Kim, R. Stewart, S.W. Kim, S.J. Yang, I.S. Shin, Y.H. Kim, and J.S. Yoon Interactions between life stressors and susceptibility genes (5-HTTLPR and BDNF) on depression in Korean elders Biological Psychiatry 62 2007 423 428
24. S.Y. Kim, J.M. Kim, S.W. Kim, I.S. Shin, M.H. Park, J.H. Yoon, C. Choi, and J.S. Yoon Associations between plasma cytokines and depressive mood in patients with breast cancer International Journal of Psychiatry in Medicine 43 2012 1 17
25. M. Kubera, A. Basta-Kaim, and M. Papp The effect of chronic treatment with imipramine on the immunoreactivity of animals subjected to a chronic mild stress model of depression Immunopharmacology 30 1995 225 230
26. B. Leonard, and M. Maes Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression Neuroscience and Biobehavioral Reviews 36 2012 764 785
27. J.M. Loftis, M. Huckans, and B.J. Morasco Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies Neurobiology of Disease 37 2010 519 533
28. X.Y. Lou, G.B. Chen, L. Yan, J.Z. Ma, J. Zhu, R.C. Elston, and M.D. Li A generalized combinational approach for detecting gene-by-gene and gene-by-environment interactions with application to Nicotine dependence American Journal of Human Genetics 80 2007 1125 1137
29. M. Maes, E. Bosmans, E. Suy, C. Vandervorst, C. De Jonckheere, and J. Raus Immune disturbances during major depression: upregulated expression of interleukin-2 receptors Neuropsychobiology 24 1990-1991 115 120
30. M. Maes, E. Bosmans, E. Suy, C. Vandervorst, C. DeJonckheere, and J. Raus Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1 beta and soluble interleukin-2 receptor production Acta Psychiatrica Scandinavica 84 1991 379 386
31. M. Maes A review on the acute phase response in major depression Reviews Neuroscience 4 1993 407 416
32. M. Maes, E. Bosmans, H.Y. Meltzer, S. Scharpe, and E. Suy Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression? American Journal of Psychiatry 150 1993 1189 1193
33. M. Maes Evidence for an immune response in major depression: a review and hypothesis Progress in Neuro-Psychopharmacology and Biological Psychiatry 19 1995 11 38
34. M. Maes, C. Song, A.H. Lin, S. Bonaccorso, G. Kenis, R. De Jongh, E. Bosmans, and S. Scharpé Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion Neuropsychopharmacology 20 1999 370 379
35. M.J. Massie Prevalence of depression in patients with cancer Journal of National Cancer Institute Monograph 32 2004 57 71
36. M.C. McCulley, I.N. Day, and C. Holmes Association between interleukin 1-β promoter (-511) polymorphism and depressive symptoms in Alzheimer's disease American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 124B 2004 50 53
37. I.V. Meira-Lima, A.C. Pereira, G.F. Mota, M. Floriano, F. Araujo, A.J. Mansur, J.E. Krieger, and H. Vallada Analysis of a polymorphism in the promoter region of the tumor necrosis factor-α gene in schizophrenia and bipolar disorder: further support for an association with schizophrenia Molecular Psychiatry 8 2003 718 720
38. C.A. Meyers, M. Albitar, and E. Estey Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome Cancer 104 2005 788 793
39. O. Mikova, R. Yakimova, E. Bosmans, G. Kenis, and M. Maes Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis European Neuropsychopharmacology 11 2001 203 208
40. V.L. Misener, L. Gomez, K.G. Wigg, P. Luca, N. King, E. Kiss, G. Daróczi, K. Kapornai, Z. Tamas, L. Mayer, J. Gádoros, I. Baji, J.L. Kennedy, M. Kovacs, A. Vetró, and C.L. Barr International Consortium for Childhood-Onset Mood DisordersCytokine genes TNF, IL1A, IL1B, IL6, IL1RN and IL10, and childhood-onset mood disorders. Neuropsychobiology 58 2008 71 80
41. S. Moylan, M. Maes, N.R. Wray, and M. Berk The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications Molecular Psychiatry 2012 doi: 10.1038/mp.2012.33. [Epub ahead of print]
42. D.L. Musselman, D.H. Lawson, J.F. Gumnick, A.K. Manatunga, S. Penna, R.S. Goodkin, K. Greiner, C.B. Nemeroff, and A.H. Miller Paroxetine for the prevention of depression induced by high-dose interferon alpha The New England Journal of Medicine 344 2001 961 966
43. D.L. Musselman, A.H. Miller, M.R. Porter, A. Manatunga, F. Gao, S. Penna, B.D. Pearce, J. Landry, S. Glover, J.S. McDaniel, and C.B. Nemeroff Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings American Journal of Psychiatry 158 2001 1252 1257
44. NCI-NHGRI Working Group on Replication in Association Studies, S.J. Chanock, T. Manolio, M. Boehnke, E. Boerwinkle, D.J. Hunter, G. Thomas, J.N. Hirschhorn, G. Abecasis, D. Altshuler, J.E. Bailey-Wilson, L.D. Brooks, L.R. Cardon, M. Daly, P. Donnelly, J.F. Fraumeni Jr.; N.B. Freimer, D.S. Gerhard, C. Gunter, A.E. Guttmacher, M.S. Guyer, E.L. Harris, J. Hoh, R. Hoover, C.A. Kong, K.R. Merikangas, C.C. Morton, L.J. Palmer, E.G. Phimister, J.P. Rice, J. Roberts, C. Rotimi, M.A. Tucker, K.J. Vogan, S. Wacholder, E.M. Wijsman, D.M. Winn, and F.S. Collins Replicating genotype-phenotype association Nature 447 2007 655 660
45. C. Otte, J. McCaffery, S. Ali, and M.A. Whooley Association of a serotonin transporter polymorphism (5-HTTLPR) with depression, perceived stress, and norepinephrine in patients with coronary disease: the heart and soul study American Journal of Psychiatry 164 2007 1379 1384
46. M. Reich, A. Lesur, and C. Perdrizet-Chevallier Depression, quality of life and breast cancer: a review of the literature Breast Cancer Research and Treatment 110 2008 9 17
47. C.C. Reyes-Gibby, X. Wu, M. Spitz, R. Kurzrock, M. Fisch, E. do Bruera, and S. Shete Molecular epidemiology, cancer-related symptoms, and cytokines pathway Lancet Oncology 9 2008 777 785
48. A. Rosa, V. Peralta, S. Papiol, M.J. Cuesta, F. Serrano, A. Martinez-Larrea, and L. Fañanás Interleukin-1β (IL-1β) gene and increased risk for the depressive symptom-dimension in schizophrenia spectrum disorders American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 124B 2004 10 14
49. N. Rothman, C.F. Skibola, S.S. Wang, G. Morgan, Q. Lan, M.T. Smith, J.J. Spinelli, E. Willett, S. De Sanjose, P. Cocco, S.I. Berndt, P. Brennan, A. Brooks-Wilson, S. Wacholder, N. Becker, P. Hartge, T. Zheng, E. Roman, E.A. Holly, P. Boffetta, B. Armstrong, W. Cozen, M. Linet, F.X. Bosch, M.G. Ennas, T.R. Holford, R.P. Gallagher, S. Rollinson, P.M. Bracci, J.R. Cerhan, D. Whitby, P.S. Moore, B. Leaderer, A. Lai, C. Spink, S. Davis, R. Bosch, A. Scarpa, Y. Zhang, R.K. Severson, M. Yeager, S. Chanock, and A. Nieters Genetic variation in TNF and IL 10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium Lancet Oncology 7 2006 27 38
50. T. Saarelainen, P. Hendolin, G. Lucas, E. Koponen, M. Sairanen, E. MacDonald, K. Agerman, A. Haapasalo, H. Nawa, R. Aloyz, P. Ernfors, and E. Castrén Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects Journal of Neuroscience 23 2003 349 357
51. O.J. Schiepers, M.C. Wichers, and M. Maes Cytokines and major depression Progress in Neuro-Psychopharmacology and Biological Psychiatry 29 2005 201 217
52. S.C. Sepah, and J.E. Bower Positive affect and inflammation during radiati on treatment for breast and prostate cancer Brain, Behavior, and Immunity 23 2009 1068 1072
53. B. Seruga, H. Zhang, L.J. Bernstein, and I.F. Tannock Cytokines and their relationship to the symptoms and outcome of cancer Nature Reviews Cancer 8 2008 887 899
54. D.V. Sheehan, Y. Lecrubier, K.H. Sheehan, P. Amorim, J. Janavs, E. Weiller, T. Hergueta, R. Baker, and G.C. Dunbar The mini-international neuropsychiatric interview (M.I.N.I): the development and validation of a structured diagnostic psychiatric interview for DSM-VI and ICD-10 Journal of Clinical Psychiatry 59 1988 22 33
55. E.J. Shim, Y.W. Shin, H.J. Jeon, and B.J. Hahm Distress and its correlates in Korean cancer patients: pilot use of the distress thermometer and the problem list Psycho-Oncology 17 2008 548 555
56. C. Song, and E. Leonard An acute phase response in the olfactory bulbectomised rat: effect of sertraline treatment Medical Science Research 22 1994 313 314
57. J.L. Steel, D.A. Geller, T.C. Gamblin, M.C. Olek, and B.I. Carr Depression, immunity, and survival in patients with hepatobiliary carcinoma Journal of Clinical Oncology 25 2007 2397 2405
58. M. Stein, A.H. Miller, and R.L. Trestman Depression, the immune system, and health and illness Archives of General Psychiatry 48 1991 171 177
59. P.F. Sullivan, J.M. Neale, and K.S. Kendler Genetic epidemiology of major depression: review and meta-analysis American Journal of Psychiatry 157 2000 1552 1562
60. A.M. Tsimberidou, E. Estey, S. Wen, S. Pierce, H. Kantarjian, M. Albitar, and R. Kurzrock The prognostic significance of cytokine levels in newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromes Cancer 113 2008 1605 1613
61. Z. Xia, J.W. DePierre, and L. Nässberger Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells Immunopharmacology 34 1996 27 37
62. S.W. Yoo, Y.S. Kim, J.S. Noh, K.S. Oh, C.H. Kim, K. Namkoong, J.H. Chae, G.C. Lee, S.I. Jeon, K.J. Min, D.J. Oh, E.J Joo, H.J. Park, Y.H. Choi, and S.J. Kim Validity of Korean version of the mini-international neuropsychiatric interview Anxiety Mood 2 2006 50 55
63. Y.W. Yu, T.J. Chen, C.J. Hong, H.M. Chen, and S.J. Tsai Association study of the interleukin-1 beta (C-511T) genetic polymorphism with major depressive disorder, associated symptomatology, and antidepressant response Neuropsychopharmacology 28 2003 1182 1185